Zhang 2024 — Mazdutide in Chinese Patients With Type 2 Diabetes

Diabetes Care

Bo Zhang, et al.

Summary

Mazdutide demonstrated clinically meaningful HbA1c and body-weight reductions in Chinese patients with type 2 diabetes.

Study Details

Study Design

Randomized controlled phase 2 trial

Indication

Type 2 diabetes

Intervention

Mazdutide up to 6 mg vs placebo

Species

Human

Risk of Bias Assessment

Sponsor-funded; China-only population